Tiny radioactive beads tested to zap prostate tumors from inside
NCT ID NCT06192758
Summary
This early study is testing a new way to treat prostate cancer by delivering tiny radioactive glass beads directly into the tumor's blood supply. The goal is to find the safest and most effective dose of this targeted radiation therapy for men with localized prostate cancer who have declined or are not eligible for standard treatments. Researchers will closely monitor 36 participants for safety, side effects, and quality of life over five years.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Northwestern Memorial Hospital
Chicago, Illinois, 60611, United States
Conditions
Explore the condition pages connected to this study.